Written question asked by Kevin Barron (Labour) on Monday, 25 February 2019, in the House of Commons. It was due for an answer on Thursday, 28 February 2019 (named day). A holding answer was provided on Thursday, 28 February 2019. A substantive answer was provided by Steve Brine (Conservative) on Thursday, 21 March 2019 on behalf of the Department of Health and Social Care.
UK Antimicrobial Resistance Diagnostics Collaborative
- Question
-
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 February 2019 to Question 219373 on UK Antimicrobial Resistance Diagnostics Collaborative, what representations his Department has received from members of that Collaborative; if he will publish the names of its members; and whether a Chair of that Collaborative has been appointed.
- Answer
-
NHS England established the United Kingdom Antimicrobial Resistance (AMR) Diagnostics Collaborative in 2018 to deliver the UK’s diagnostic ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostic elements of the new five-year UK AMR national action plan, published in January this year.
The work of the Collaborative contributes directly to the Government’s commitments on AMR, and the Collaborative’s secretariat communicates with the Department on a regular basis and it has been represented by its secretariat and former chair in the UK AMR Programme’s governance groups.
The Collaborative’s chair remains vacant while NHS England develops detailed plans to support the implementation of the new national plan on AMR. As part of this work, the membership of the Collaborative is under review.
Current membership is drawn from a range of stakeholders across Government and its agencies, the devolved administrations, the health system, veterinary medicine, professional bodies, academia, the research community and industry. Members at or above ‘very senior manager’ (VSM) level and partner agencies involved in the Collaborative are listed in the following table.
Members of the UK Antimicrobial Resistance Diagnostics Collaborative at or above VSM level
Organisation
Mohamed Sadak
Health Education England
Marion Lyons
Welsh Government
Gerry Waldron
Public Health Agency Northern Ireland
Neil Woodford
Public Health England
Partner Agencies
NHS Scotland
NHS England
NHS Sheffield Clinical Commissioning Group
Department of Health and Social Care
NHS Improvement
University of Bristol
Institute of Biomedical Science
Association of Clinical Biochemistry and Laboratory Medicine
UK Standards for Microbiology Investigations
Royal College of Pathology
Royal College of General Practice
National Institute for Health and Care Excellence (NICE) Medical Technology Guidance
Sherwood Forrest NHS Foundation Trust
Royal College of Nursing
University of Surrey
Addenbrookes Hospital NHS Trust
University of Edinburgh
Medical Research Council
British In Vitro Diagnostic Association
NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative
Innovate UK
NICE
Royal Cornwall Hospital
Kingston University
Department for Environment, Food and Rural Affairs
Responsible Use of Medicines in Agriculture Alliance
University of Liverpool
Ulster University
University of Exeter
Westpoint Farm Vets
University of Nottingham
Centre for Ecology and Hydrology
Cardiff University
Guy’s and St Thomas’ Hospital NHS Foundation Trust
Glasgow Caledonian University
Secondary information
- Type
- Written question
- Reference
- 225396
- Session
- 2017-19
- Related items
-
UK Antimicrobial Resistance Diagnostics Collaborative
Thursday, 14 February 2019
Written questions
House of Commons
- Subjects
- UK Antimicrobial Resistance Diagnostics Collaborative
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-03-21 16:58:44 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/225396
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/225396
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/225396